Biotech

All Articles

Genentech to close cancer cells immunology analysis team

.Genentech will close its own cancer cells immunology research department, and also unit head as wel...

Kezar falls strong lump yet to verify its truly worth in period 1 trial

.Kezar Lifestyle Sciences is actually losing its dim period 1 strong tumor medication as the biotech...

Acelyrin falls izokibep, drops 3rd of workers

.Regardless of izokibep keeping its own newly found winning touch in the center, Acelyrin is no more...

Rivus' period 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medicine cand...

Ovid standstills preclinical job, IV plan after soticlestat fall short

.Ovid Therapeutics currently uncovered last month that it was actually trimming its head count as th...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has opened a $700 million R&ampD facility in the Boston Seaport, improving its RNA and DN...

Boundless Bio makes 'moderate' cutbacks 5 months after $100M IPO

.Simply 5 months after protecting a $100 million IPO, Limitless Bio is already giving up some worker...

Halda's $126M is going to evolve 'hold as well as kill' cyst drugs

.The preliminary phases of oncology R&ampD aren't except interesting new techniques, and Halda Thera...

Lykos 'regrets' certainly not revealing research study transgressions with author

.Psychopharmacology has actually taken 3 write-ups about midstage medical trial information evaluati...

Analysts examine Avidity's DMD win, uncovering subtleties in data

.Avidity Biosciences pleased capitalists along with phase 1/2 information in Duchenne muscle dystrop...